Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
BRÜSSEL (dpa-AFX) - Die EU-Kommission hat die Übernahme des schweizerischen Augenheil-Spezialisten Alcon durch den Pharmakonzern Novartis unter Auflagen genehmigt. Das ebenfalls in der Schweiz...
BASEL (dpa-AFX) - Der Schweizer Pharmakonzern Novartis <NOVN.VT<NOT.FSE>T.FSE> will das Augenheilkunde-Unternehmen Alcon vollständig übernehmen. Mit dem Schritt ins Verbrauchergeschäft...
BASEL (dpa-AFX) - Der Schweizer Pharmakonzern Novartis <NOVN.VT<NOT.FSE>T.FSE> will das Augenheilkunde-Unternehmen Alcon vollständig schlucken. Wie der Konzern am Montag mitteilte, will...
-- Alcon takes over development of POT-4 as a treatment for patients with age-related macular degeneration -- Deal provides path for Alcon to acquire Potentia LOUISVILLE, Ky., Oct. 23...
Presentation to be Webcast on September 29, 2009 EMERYVILLE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE-AMEX: NBY) http://www.novabaypharma.com/, a clinical...
In the news release, Agency.com Helps Launch the New Alcon.com, issued earlier today by Agency.com over PR Newswire, we are advised by the company that the phone number in the contact...
Alcon Views AMO Patent Lawsuit as Meritless FORT WORTH, Texas, Dec. 16 /PRNewswire-FirstCall/ -- On December 3, 2003, Advanced Medical Optics (AMO) filed a complaint against Alcon Laboratories...
RNS Number:8575S Acal PLC 04 December 2003 Appointment of Mr Graham Williams as a Non-Executive Director On 1st December 2003 Acal plc announced the appointment of Mr Graham Williams...
RNS Number:6614S Acal PLC 01 December 2003 FOR RELEASE 7:00AM 1 DECEMBER 2003 ACAL plc (Leading pan-European, value added distributor providing specialist design-in, sales and...
RNS Number:9575R Acal PLC 12 November 2003 FOR RELEASE 7.00AM 12 NOVEMBER 2003 ACAL PLC (Acal is a leading European value-added distributor providing specialist design-in, sales...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
